Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Surg Int ; 31(12): 1195-8, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26474572

ABSTRACT

Pancreatic pseudoaneurysm is a rare but potentially fatal complication in pancreatitis; however, the incidence in children is not well established. Surgery has been the mainstay of treatment; however, we report a case of PSA associated with pancreatitis in a 6-year-old boy, which was successfully managed endovascularly.


Subject(s)
Aneurysm, False/complications , Aneurysm, False/therapy , Embolization, Therapeutic , Pancreatitis/complications , Aneurysm, False/diagnostic imaging , Child , Humans , Male , Pancreas/diagnostic imaging , Pancreatitis/diagnostic imaging , Tomography, X-Ray Computed , Treatment Outcome
2.
J Vasc Interv Radiol ; 14(3): 279-90, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12631632

ABSTRACT

PURPOSE: To determine the antitumoral activity and radiographic response pattern of intraarterial administration of a selective replication-competent adenovirus in patients with hepatic metastases from gastrointestinal carcinomas. MATERIALS AND METHODS: Thirty-five patients were treated, seven in the dose-escalation phase and 28 at high doses. Inclusion criteria allowed mild laboratory value and performance status abnormalities and as much as 50% replacement of hepatic volume by tumor. An attenuated adenovirus that selectively replicates in p53-deficient cells (Onyx-015) was administered by hepatic arterial infusion at doses as high as 2 x 10(12) particles for two cycles. Subsequent cycles (maximum of eight total) were administered in combination with intravenous 5-fluorouracil (5-FU) and leucovorin. RESULTS: Tumor responses were demonstrated in combination with chemotherapy, even in 5-FU-resistant patients. The 15 patients who responded radiographically showed a pattern of acute tumor enlargement despite normalization of laboratory and clinical parameters, followed by very slow regression of tumor size. Radiographic response did not correlate with p53 status. Median survival of radiographic responders (475 days) was significantly longer than that of nonresponders (143 days). CONCLUSIONS: Hepatic arterial infusion of the replication-selective adenovirus Onyx-015 in combination with chemotherapy resulted in tumor regressions in select patients, including some in whom previous chemotherapy had failed. A biphasic radiographic response pattern was demonstrated. The mechanism of action appears to be more complex than that seen in vitro.


Subject(s)
Adenoviridae , Gastrointestinal Neoplasms/pathology , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Viral Vaccines/therapeutic use , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols , Female , Fluorouracil/administration & dosage , Genetic Therapy , Humans , Infusions, Intra-Arterial , Leucovorin/administration & dosage , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/pathology , Male , Middle Aged , Radiography , Treatment Outcome , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/therapeutic use , Viral Vaccines/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...